Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370AM2)(COMPLETED)
This study has been completed.
Study NCT00039871 Information provided by Schering-Plough
First Received: June 13, 2002 Last Updated: October 13, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis
Hepatitis C, Chronic
Fibrosis
Liver Cirrhosis
Additional conditions recognized in this trial
Hepatitis C
Hepatitis, Chronic
More general conditions related to this trial
Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
Pathologic Processes
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
REBETOL (ribavirin; SCH 18908)
Additional drug interventions recognized in this trial
Interferon Alfa-2b
Interferon-alpha
Peginterferon alfa-2b
Ribavirin
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antimetabolites
Antineoplastic Agents
Antiviral Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Schering-Plough
Back to top of Main Content
